Decreased toll-like receptor-4/myeloid differentiation factor 88 response leads to defective interleukin-1 (3 production in term low birth weight newborns

Pediatric Infectious Disease Journal

Volumn 33, Issue 12, 2014, Pages 1270-1276

  Singh, Vikas Vikram ^a   Chauhan, Sudhir Kumar ^a   Rai, Richa ^a   Kumar, Ashok ^b   Rai, Geeta ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cord blood; Cytokines; Immunoglobulins; Low birth weight; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; IL10 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; INNATE IMMUNITY; LOW BIRTH WEIGHT; MORBIDITY; NEWBORN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; BIOSYNTHESIS; BLOOD; COMMUNICABLE DISEASE; DISEASE PREDISPOSITION; FEMALE; FETUS BLOOD; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; MALE; MONONUCLEAR CELL; PREGNANCY; SECRETION (PROCESS);

COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERLEUKIN-10; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MYELOID DIFFERENTIATION FACTOR 88; PREGNANCY; TOLL-LIKE RECEPTOR 4;

EID: 84926065722     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000416     Document Type: Article

References (33)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801.
2. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol. 2002;270:109-120.
3. Pålsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 2004;113:153-162.
4. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4:.
5. Olive C. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Rev Vaccines. 2012;11:237-256.
6. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
7. Ambalavanan N, Carlo WA, D'Angio CT, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009;123:1132-1141.
8. Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633-652.
9. Basu S, Rathore P, Bhatia BD. Predictors of mortality in very low birth weight neonates in India. Singapore Med J. 2008;49:556-560.
10. Ballot DE, Chirwa TF, Cooper PA. Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg. BMC Pediatr. 2010;10:30.
11. Chang SC, Lin CH, Lin YJ, et al. Mortality, morbidity, length and cost of hospitalization in very-low-birth-weight infants in the era of National Health Insurance in Taiwan: a medical center's experience. Acta Paediatr Taiwan. 2000;41:308-312.
12. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-291.
13. Stoll BJ, Hansen NI, Adams-Chapman I, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA. 2004;292:2357-2365.
14. Moro M, Figueras-Aloy J, Fernández C, et al.; Grupo SEN 1500. Mortality for newborns of birthweight less than 1500 g in Spanish neonatal units (2002-2005). Am J Perinatol. 2007;24:593-601.
15. Fanaroff AA, Stoll BJ, Wright LL, et al.; NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:147.e1-147.e8.
16. National Neonatolog Forum. Available at: http://www.savethechildren.org/publications/india-pdf/SOIN-Document.pdf. Accessed June 3, 2014.
17. Singh VV, Chauhan SK, Rai R, et al. Decreased pattern recognition receptor signaling, interferon-signature, and bactericidal/permeability-increasing protein gene expression in cord blood of term low birth weight human newborns. PLoS One. 2013;8:e62845.
18. von Bernuth H, Ku CL, Rodriguez-Gallego C, et al. A fast procedure for the detection of defects in Toll-like receptor signaling. Pediatrics. 2006;118:2498-2503.
19. Förster-Waldl E, Sadeghi K, Tamandl D, et al. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr Res. 2005;58:121-124.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods. 2001;25:402-408.
21. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379-390.
22. Xu Y, Tao X, Shen B, et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 2000;408:111-115.
23. Sahoo M, Ceballos-Olvera I, del Barrio L, et al. Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. Scientific World Journal. 2011;11:2037-2050.
24. Kenny EF, O'Neill LA. Signalling adaptors used by Toll-like receptors: an update. Cytokine. 2008;43:342-349.
25. Sadeghi K, Berger A, Langgartner M, et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis. 2007;195:296-302.
26. Kollmann TR, Levy O, Montgomery RR, et al. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity. 2012;37:771-783.
27. Cuenca AG, Wynn JL, Moldawer LL, et al. Role of innate immunity in neonatal infection. Am J Perinatol. 2013;30:105-112.
28. Tissières P, Ochoda A, Dunn-Siegrist I, et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. PLoS One. 2012;7:e32863.
29. Palmeira P, Quinello C, Silveira-Lessa AL, et al. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:985646.
30. Okoko BJ, Wesumperuma HL, Fern J, et al. The transplacental transfer of IgG subclasses: influence of prematurity and low birthweight in the Gambian population. Ann Trop Paediatr. 2002;22:325-332.
31. Costa-Carvalho BT, Vieria HM, Dimantas RB, et al. Transfer of IgG subclasses across placenta in term and preterm newborns. Braz J Med Biol Res. 1996;29:201-204.
32. Doroudchi M, Samsami Dehaghani A, Emad K, et al. Placental transfer of rubella-specific IgG in fullterm and preterm newborns. Int J Gynaecol Obstet. 2003;81:157-162.
33. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2013;7:CD000361.